Aloysious Ssemaganda

Aloysious Ssemaganda

Auto-generated profile, based on publicly available information

Aloysious Ssemaganda

Department of National Health Laboratory and Diagnostics Services, Central Public Health Laboratories (NHLDS-CPHL), Ministry of Health, P.O. Box 7272, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAloysious Ssemaganda
Aloysious Ssemaganda
HNHuong Mai Nguyen
Huong Mai Nguyen
FNFaisal Nuhu
Faisal Nuhu
NJNaima Jahan
Naima Jahan
CCCatherine M. Card
Catherine M. Card
LMLyle R. McKinnon
Lyle R. McKinnon
Vaccines against SARS-CoV-2 have shown high efficacy in clinical trials, yet a full immunologic characterization of these vaccines, particularly within the human upper respiratory tract, is less well known. Here, we enumerate and phenotype T cells in nasal mucosa and blood using flow cytometry before and after vaccination with the Pfizer-BioNTech COVID-19 vaccine (n = 21). Tissue-resident memory (Trm) CD8+ T cells expressing CD69+CD103+ increase in number ~12 days following the first and second doses, by 0.31 and 0.43 log10 cells per swab respectively (p = 0.058 and p = 0.009 in adjusted linear mixed models). CD69+CD103+CD8+ T cells in the blood decrease post-vaccination. Similar increases in nasal CD8+CD69+CD103− T cells are observed, particularly following the second dose. CD4+ cells co-expressing CCR6 and CD161 are also increased in abundance following both doses. Stimulation of nasal CD8+ T cells with SARS-CoV-2 spike peptides elevates expression of CD107a at 2- and 6-months (p = 0.0096) post second vaccine dose, with a subset of donors also expressing increased cytokines. These data suggest that nasal T cells may be induced and contribute to the protective immunity afforded by this vaccine.

1 January 2018 in Metallomics
Verified
Journal Article
Open access
PDF file
ASAloysious Ssemaganda
Aloysious Ssemaganda
LLLeanne M. Low
Leanne M. Low
KVKrista R. Verhoeft
Krista R. Verhoeft
MWMathias Wambuzi
Mathias Wambuzi
BKBarbarah Kawoozo
Barbarah Kawoozo
MGMichael F. Good
Michael F. Good
The asexual blood-stagePlasmodiumparasite attenuating properties of gold(i) phosphine compounds are exploited in a novel strategy for malaria vaccine development.

16 August 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
ANAnnemarie Namuniina
Annemarie Namuniina
EMEnoch S. Muyanja
Enoch S. Muyanja
VBVictoria M. Biribawa
Victoria M. Biribawa
BOBrenda A. Okech
Brenda A. Okech
ASAloysious Ssemaganda
Aloysious Ssemaganda
ARAndrew D. Redd
Andrew D. Redd
The estimated mortality rate of the SARS-CoV-2 pandemic varied greatly around the world. In particular, multiple countries in East, Central, and West Africa had significantly lower rates of COVID-19 related fatalities than many resource-rich nations with significantly earlier wide-spread access to life-saving vaccines. One possible reason for this lower mortality could be the presence of pre-existing cross-reactive immunological responses in these areas of the world. To explore this hypothesis, an exploratory study of stored peripheral blood mononuclear cells (PBMC) from Ugandans collected from 2015–2017 prior to the COVID-19 pandemic (n = 29) and from hospitalized Ugandan COVID-19 patients (n = 3) were examined using flow-cytometry for the presence of pre-existing SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell populations using four T-cell epitope mega pools. Of pre-pandemic participants, 89.7% (26/29) had either CD4+ or CD8+, or both, SARS-CoV-2 specific T-cell responses. Specifically, CD4+ T-cell reactivity (72.4%) and CD8+ T-cell reactivity (65.5%) were relatively similar, and 13 participants (44.8%) had both types of cross-reactive types of T-cells present. There were no significant differences in response by sex in the population, however this may be in part due to the limited sample size examined. The rates of cross-reactive T-cell populations in this exploratory Ugandan population appears higher than previous estimates from resource-rich countries like the United States (20–50% reactivity). It is unclear what role, if any, this cross-reactivity played in decreasing COVID-19 related mortality in Uganda and other African countries, but does suggest that a better understanding of global pre-existing immunological cross-reactivity could be an informative data of epidemiological intelligence moving forward.

14 November 2016 in Malaria Journal
Verified
Journal Article
Open access
PDF file
SYSergey Yegorov
Sergey Yegorov
RGRonald M. Galiwango
Ronald M. Galiwango
ASAloysious Ssemaganda
Aloysious Ssemaganda
MMMoses Muwanga
Moses Muwanga
IWIrene Wesonga
Irene Wesonga
RKRupert Kaul
Rupert Kaul
The malaria burden in sub-Saharan Africa (SSA) has fallen substantially. Nevertheless, malaria remains a serious health concern, and Uganda ranks third in SSA in total malaria burden. Epidemiological studies of adult malaria in Uganda are scarce and little is known about rates of malaria in non-pregnant adult women. This pilot study assessed malaria prevalence among adult women from Wakiso district, historically a highly malaria endemic region. Adult women using public health services were screened for malaria, HIV and pregnancy. A physician-selected subset of women presenting to the Outpatient Department of Entebbe General Hospital (EGH) with current fever (axillary temperature ≥37.5 °C) or self-reporting fever during the previous 24 h, and a positive thick smear for malaria in the EGH laboratory were enrolled (n = 86). Women who self-identified as pregnant or HIV-positive were excluded from screening. Malaria infection was then assessed using HRP2/pLDH rapid diagnostic tests (RDTs) in all participants. Repeat microscopy and PCR were performed at a research laboratory for a subset of participants. In addition, 104 women without a history of fever were assessed for asymptomatic parasitaemia using RDT, and a subset of these women screened for parasitaemia using microscopy (40 women) and PCR (40 women). Of 86 women diagnosed with malaria by EGH, only two (2.3%) had malaria confirmed using RDT, subsequently identified as a Plasmodium falciparum infection by research microscopy and PCR. Subset analysis of hospital diagnosed RDT-negative participants detected one sub-microscopic infection with Plasmodium ovale. Compared to RDT, sensitivity, specificity and PPV of hospital microscopy were 100% (CI 19.8–100), 0% (CI 0–5.32) and 2.33% (CI 0.403–8.94) respectively. Compared to PCR, sensitivity, specificity and PPV of hospital microscopy were 100% (CI 31.0–100), 0% (CI 0–34.5) and 23.1% (CI 6.16–54.0), respectively. No malaria was detected among asymptomatic women using RDT, research microscopy or PCR. Malaria prevalence among adult women appears to be low in Wakiso, but is masked by high rates of malaria overdiagnosis. More accurate malaria testing is urgently needed in public hospitals in this region to identify true causes of febrile illness and reduce unnecessary provision of anti-malarial therapy.

30 August 2024 in Journal of Global Health
Verified
Journal Article
Open access
RNRitah Namusoosa
Ritah Namusoosa
IMIbrahimm Mugerwa
Ibrahimm Mugerwa
Keneth Iceland KasoziKeneth Iceland Kasozi
Keneth Iceland Kasozi
AMAllan Muruta
Allan Muruta
GNGrace Najjuka
Grace Najjuka
AMAdrian Muwonge
Adrian Muwonge
Antibiotic resistance (ABR) is a phenomenon where bacteria become unresponsive to antibiotics, and globally, it is estimated to cause 1.27 million deaths [1]. This disproportionately affects people living in sub-Saharan Africa, where 27.3 deaths per 100 000 population lose their lives due to hard-to-treat infections [2]. Vulnerable populations, including neonates, infants, and pregnant mothers, bear the […]

1 February 2020 in Vaccine
Verified
Journal Article
Closed access
ASAloysious Ssemaganda
Aloysious Ssemaganda
AGAshwini Kumar Giddam
Ashwini Kumar Giddam
LLLeanne M. Low
Leanne M. Low
XLXue Q. Liu
Xue Q. Liu
MHMei-Fong Ho
Mei-Fong Ho
MGMichael F. Good
Michael F. Good